Liver Tumor Enhancement at Hybrid Angio-CT and Comparison With Tumor and Hepatic Parenchymal Distribution of Yttrium-90 Microspheres by Positron Emission Tomography
Open Access
- 3 December 2023
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 15 (12) , e49861
Abstract
This single-center retrospective study evaluated patients who underwent treatment of a primary or secondary hepatic malignancy with injection of glass or resin yttrium-90 (90Y) microspheres with a corresponding hybrid angiography-computed tomography (angio-CT) and 90Y positron emission tomography (PET). Volumetric contours were defined by three independent observers and were used to calculate relative tumoral enhancement at angio-CT. This parameter was compared with the tumor-to-normal (T/N) activity ratio predicted by technetium-99m macro-aggregated albumin (99mTc-MAA) single photon emission computed tomography (SPECT) and microsphere activity distribution by 90Y PET. A similar correlation was observed for the enhancement ratio at angio-CT with observed microsphere distribution at 90Y PET (r=0.34) to that predicted by 99mTc-MAA SPECT (r=0.32). The enhancement ratio on angio-CT performed as well as 99mTc-MAA in the prediction of 90Y PET activity distribution. The technique could not be readily applied to tumors with large areas of hypoattenuation (necrosis) on angio-CT. With refinement and further study, this technique could be used as a quantitative adjunct to standard-of-care 99mTc-MAA SPECT for dosimetry calculations and prediction of microsphere distribution to maximize tumor response and minimize hepatotoxicity.Keywords
This publication has 14 references indexed in Scilit:
- Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trialThe Lancet Gastroenterology & Hepatology, 2021
- Analysis of differences between 99mTc-MAA SPECT- and 90Y-microsphere PET-based dosimetry for hepatocellular carcinoma selective internal radiation therapyEJNMMI Research, 2019
- Predictive Value of 99mTc-MAA SPECT for 90Y-Labeled Resin Microsphere Distribution in Radioembolization of Primary and Secondary Hepatic TumorsJournal of Nuclear Medicine, 2015
- PET/CT-Based Dosimetry in 90Y-Microsphere Selective Internal Radiation TherapyMedicine, 2015
- A multicentre comparison of quantitative 90Y PET/CT for dosimetric purposes after radioembolization with resin microspheresEuropean Journal of Nuclear Medicine and Molecular Imaging, 2015
- 99mTc-Macroaggregated Albumin Poorly Predicts the Intrahepatic Distribution of 90Y Resin Microspheres in Hepatic RadioembolizationJournal of Nuclear Medicine, 2013
- Post-radioembolization yttrium-90 PET/CT - part 2: dose-response and tumor predictive dosimetry for resin microspheresEJNMMI Research, 2013
- Post-radioembolization yttrium-90 PET/CT - part 1: diagnostic reportingEJNMMI Research, 2013
- Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumoursEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Diagnostic pharmaco-scintigraphy with hepatic intraarterial technetium-99m macroaggregated albumin in the determination of tumour to non-tumour uptake ratio in hepatocellular carcinomaBritish Journal of Radiology, 1994